GeneNews Extends Term of Warrants | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – GeneNews has extended the term of certain purchase warrants to July 31, 2012.

The warrants were issued by the Canadian molecular diagnostics firm on Jan. 16, 2009 and Feb. 11, 2009, entitling holders to purchase one common share of GeneNews at an exercise price of C$.25 ($US.25) per share.

There are 1 million warrants that were set to expire on Jan. 16, 2012, and there are 1,978,065 warrants that were set to expire on Feb. 11, 2012.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Cell this week: characterization of functional genomic features in breast cancer cell lines, epigenetic pattern linked to obesity, and more.

President Obama's proposed budget for fiscal year 2017 includes an increase for NIH, but seeks some of it as mandatory funding.

Sure Genomics begins to offer direct-to-consumer genome sequencing for $2,500.

Intelligence officials in the US have added gene editing to a list of weapons of mass destruction.

Mar
03
Sponsored by
Agilent Technologies

This webinar will discuss the use of a hybrid capture-based FFPE DNA sequencing methodology with the potential for advancing precision oncology studies.